Page 1 of 1

Hat tip to hay flick YMB

Posted: Sun Feb 09, 2020 6:09 pm
by biopearl123

Re: Hat tip to hay flick YMB

Posted: Sun Feb 09, 2020 7:47 pm
by biopearl123
Worth a read in light of the WIPO post:

https://www.nature.com/articles/leu2013 ... rigin=ppub

Re: Hat tip to hay flick YMB

Posted: Sun Feb 09, 2020 9:33 pm
by Ryan
Still all about the trial(s), but this is interesting. Thanks to hay flick, even the name delivers knowledge, but there is no “limit” to the knowledge and latest news he’s delivering. (It’s a nerd joke.)

Re: Hat tip to hay flick YMB

Posted: Mon Feb 10, 2020 2:15 am
by biopearl123
Ryan, I think you were the one who said Geron was screening on the basis of molecular signature and I took issue since there was no mention on the clinical trials site. Looks like you will tun out to be right for future use!! I hope so. Regards, bp

Re: Hat tip to hay flick YMB

Posted: Mon Feb 10, 2020 4:01 pm
by cheng_ho
No, you were right, biopearl. Geron isn't doing genetic screening in the trials... and so far they've recruited only half the patients they need for the MDS trial, even just taking whatever victims Paraxel can find.

This is just a hope for the future. Maybe in a Phase 3 design for MF?